Cargando…
Comparison of dried blood spot and plasma sampling for untargeted metabolomics
INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340475/ https://www.ncbi.nlm.nih.gov/pubmed/34164733 http://dx.doi.org/10.1007/s11306-021-01813-3 |
_version_ | 1783733781276917760 |
---|---|
author | Tobin, Nicole H. Murphy, Aisling Li, Fan Brummel, Sean S. Taha, Taha E. Saidi, Friday Owor, Maxie Violari, Avy Moodley, Dhayendre Chi, Benjamin Goodman, Kelli D. Koos, Brian Aldrovandi, Grace M. |
author_facet | Tobin, Nicole H. Murphy, Aisling Li, Fan Brummel, Sean S. Taha, Taha E. Saidi, Friday Owor, Maxie Violari, Avy Moodley, Dhayendre Chi, Benjamin Goodman, Kelli D. Koos, Brian Aldrovandi, Grace M. |
author_sort | Tobin, Nicole H. |
collection | PubMed |
description | INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV. METHODS. Untargeted metabolomics was performed on archived paired maternal plasma and dried blood spots from n=79 women enrolled in a large clinical trial. RESULTS. A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R(2)=0.54, p<0.001) exceeded that of the sample type (R(2)=0.21, p<0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho=0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively). CONCLUSION. Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands. |
format | Online Article Text |
id | pubmed-8340475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
record_format | MEDLINE/PubMed |
spelling | pubmed-83404752022-06-23 Comparison of dried blood spot and plasma sampling for untargeted metabolomics Tobin, Nicole H. Murphy, Aisling Li, Fan Brummel, Sean S. Taha, Taha E. Saidi, Friday Owor, Maxie Violari, Avy Moodley, Dhayendre Chi, Benjamin Goodman, Kelli D. Koos, Brian Aldrovandi, Grace M. Metabolomics Article INTRODUCTION. Untargeted metabolomics holds significant promise for biomarker detection and development. In resource-limited settings, a dried blood spot (DBS)-based platform would offer significant advantages over plasma-based approaches that require a cold supply chain. OBJECTIVES. The primary goal of this study was to compare the ability of DBS- and plasma-based assays to characterize maternal metabolites. Utility of the two assays was also assessed in the context of a case-control predictive model in pregnant women living with HIV. METHODS. Untargeted metabolomics was performed on archived paired maternal plasma and dried blood spots from n=79 women enrolled in a large clinical trial. RESULTS. A total of 984 named biochemicals were detected across both plasma and DBS samples, of which 627 (63.7%), 260 (26.4%), and 97 (9.9%) were detected in both plasma and DBS, plasma alone, and DBS alone, respectively. Variation attributable to study individual (R(2)=0.54, p<0.001) exceeded that of the sample type (R(2)=0.21, p<0.001), suggesting that both plasma and DBS were capable of differentiating individual metabolomic profiles. Log-transformed metabolite abundances were strongly correlated (mean Spearman rho=0.51) but showed low agreement (mean intraclass correlation of 0.15). However, following standardization, DBS and plasma metabolite profiles were strongly concordant (mean intraclass correlation of 0.52). Random forests classification models for cases versus controls identified distinct feature sets with comparable performance in plasma and DBS (86.5% versus 91.2% mean accuracy, respectively). CONCLUSION. Maternal plasma and DBS samples yield distinct metabolite profiles highly predictive of the individual subject. In our case study, classification models showed similar performance albeit with distinct feature sets. Appropriate normalization and standardization methods are critical to leverage data from both sample types. Ultimately, the choice of sample type will likely depend on the compounds of interest as well as logistical demands. 2021-06-23 /pmc/articles/PMC8340475/ /pubmed/34164733 http://dx.doi.org/10.1007/s11306-021-01813-3 Text en https://creativecommons.org/licenses/by/4.0/This AM is a PDF file of the manuscript accepted for publication after peer review, when applicable, but does not reflect post-acceptance improvements, or any corrections. Use of this AM is subject to the publisher’s embargo period and AM terms of use. Under no circumstances may this AM be shared or distributed under a Creative Commons or other form of open access license, nor may it be reformatted or enhanced, whether by the Author or third parties. See here for Springer Nature’s terms of use for AM versions of subscription articles: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms |
spellingShingle | Article Tobin, Nicole H. Murphy, Aisling Li, Fan Brummel, Sean S. Taha, Taha E. Saidi, Friday Owor, Maxie Violari, Avy Moodley, Dhayendre Chi, Benjamin Goodman, Kelli D. Koos, Brian Aldrovandi, Grace M. Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title | Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title_full | Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title_fullStr | Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title_full_unstemmed | Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title_short | Comparison of dried blood spot and plasma sampling for untargeted metabolomics |
title_sort | comparison of dried blood spot and plasma sampling for untargeted metabolomics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340475/ https://www.ncbi.nlm.nih.gov/pubmed/34164733 http://dx.doi.org/10.1007/s11306-021-01813-3 |
work_keys_str_mv | AT tobinnicoleh comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT murphyaisling comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT lifan comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT brummelseans comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT tahatahae comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT saidifriday comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT owormaxie comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT violariavy comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT moodleydhayendre comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT chibenjamin comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT goodmankellid comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT koosbrian comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics AT aldrovandigracem comparisonofdriedbloodspotandplasmasamplingforuntargetedmetabolomics |